An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20 cells by rituximab (Q30310160)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20 cells by rituximab
scientific article

    Statements

    An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20 cells by rituximab (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit